Calpain system protein expression in carcinomas of the pancreas, bile duct and ampulla

Sarah J. Storr(Nottingham University Hospitals NHS Trust), Stewart G. Martin(University of Nottingham), Abed M. Zaitoun(GlaxoSmithKline (United Kingdom)), Srinivasan Madhusudan(Nottingham University Hospitals NHS Trust), Dileep N. Lobo(Nottingham University Hospitals NHS Trust), Arvind Arora(Himalayan Institute Hospital Trust), Lindy G. Durrant(University of Nottingham)
BMC Cancer
November 9, 2012
10.1186/1471-2407-12-511
Cited by 26

Related Papers

Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer
|New England Journal of Medicine|2010|4.5k
The Attractive Female Body Weight and Female Body Dissatisfaction in 26 Countries Across 10 World Regions: Results of the International Body Project I
|Personality and Social Psychology Bulletin|2010|718
Trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer: updated results from DESTINY-Breast03, a randomised, open-label, phase 3 trial
|The Lancet|2022|664
Guidelines for Perioperative Care in Bariatric Surgery: Enhanced Recovery After Surgery (ERAS) Society Recommendations
|World Journal of Surgery|2016|607
Docetaxel versus active symptom control for refractory oesophagogastric adenocarcinoma (COUGAR-02): an open-label, phase 3 randomised controlled trial
|The Lancet Oncology|2013|605